Recent Developments in the Chemotherapy of Chagas Disease

Author: Docampo, R.

Source: Current Pharmaceutical Design, Volume 7, Number 12, 1 August 2001 , pp. 1157-1164(8)

Publisher: Bentham Science Publishers

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

Chagas disease remains an important health problem in the Americas. Advances are being made in parts of South America in blocking transmission from insect vectors or blood transfusion, but more effective chemotherapy is needed for the millions who are already infected. This is especially important since recent results have indicated that treatment is beneficial for the elimination of the chronic course of the disease. The rational development of new drugs depends on the identification of differences between human metabolism and that of the causative parasite, Trypanosoma cruzi. Recent developments in the study of the basic biochemistry of the parasite have allowed the identification of novel targets for chemotherapy, such as sterol metabolism, protein prenylation, proteases, and phospholipid metabolism, and these are the subject of this review.

Keywords: Chemotherapy; Chagas Disease; Trypanosoma cruzi; sterol metabolism; protein prenylation; proteases; phospholipid metabolism; isoprenoid biosynthesis; PROTEIN PRENYLATION; PROTEASES

Document Type: Review article

DOI: 10.2174/1381612013397546

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$55.10 plus tax Refund Policy